Nature Medicine Commentary on COVID-19 Vaccine Acceptance and Hesitancy in Low- and Middle-Income Countries

Nature Medicine Commentary on COVID-19 Vaccine Acceptance and Hesitancy in Low- and Middle-Income Countries

Template G Content Blocks
Sub Editor

Nature Medicine features commentary by Shingai Machingaidze and Charles Shey Wiysonge on the new study "COVID-19 vaccine acceptance and hesitancy in low- and middle-income countries." They argue that the findings of the study "suggest that prioritizing distribution of vaccines to LMICs is justified not only on equity grounds but also on the expectation of higher marginal returns in maximizing global coverage at a faster rate."

This study was also featured in a range of other outlets, including SciTech DailyIFL ScienceYale Insights, Cornell University, University of MinnesotaTrinity College Dublin, The London School of Economics and Political ScienceHindustan TimesBusiness StandardGalileu (in Portuguese) Helsinki TimesNaked Science (in Russian), and The Tyee.

July 16, 2021